Analgesic efficacy of ultrasound guilded external oblique and rectus abdominis (EXORA) block for liver resection surgery: A randomized controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202607576587184

Enrollment

Registered

2026-07-30

Start date

2026-01-14

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digestive System Anaesthesia

Interventions

will receive the same standard analgesia plan with block with saline .

EXORA

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: • Patients undergoing elective liver resection surgery. • The age between of 21 and 64years with a body mass index (BMI) of 18-35 kg/m2. • American Society of Anesthesiologists (ASA) class I-III. • Gender: both sexes

Exclusion criteria

Exclusion criteria: • Patient refusal. • Uncontrolled diabetes mellitus. • Mental retardation. • Use of antidepressants. • coagulopathy.. • Allergy to local anesthetics. • Infection at the site of injection. • Addiction to opioids, alcohol, or a history of any other substance abuse.

Design outcomes

Primary

Measure	Time frame
To evaluate total opoid consumption between two groups intraoperative and postoperative.	—

Secondary

Measure	Time frame
1. Time for the first request for rescue analgesia (when VAS is 4 or more). 2. To evaluate Pain control by EXORA compared to control group intraoperative by ANI value and postoperative by Visual analogue score (VAS) in each group. 3. Intraoperative and postoperative hemodynamic variables (HR & mean ABP). 4. Incidence of postoperative complication (nausea, vomiting, pulmonary complication).	—

Countries

Egypt

Contacts

Public Contactdodi mahmoud

assisted rofessore

dr.ghadamahmoud84@gmail.com01024595554

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026